Long-term Safety of Guselkumab in Patients With Active Psoriatic Arthritis: Pooled Results From 3 Randomized Clinical Trials Through Up to 2 Years
Author Type(s)
Faculty
Document Type
Abstract
Publication Date
7-1-2022
Journal Title
Journal of Rheumatology
Department
Dermatology
Recommended Citation
Rahman, P., Ritchlin, C., Mease, P., Helliwell, P., Boehncke, W. H., McInnes, I., Shawi, M., Marrache, M., Kollmeier, A., Xu, L. L., Yu, J., Wang, Y. L., & Gottlieb, A. (2022). Long-term Safety of Guselkumab in Patients With Active Psoriatic Arthritis: Pooled Results From 3 Randomized Clinical Trials Through Up to 2 Years. Journal of Rheumatology, 49 (7), 774-775. Retrieved from https://touroscholar.touro.edu/nymc_fac_abstracts/721
COinS
